SCHEMBL1532966

SCHEMBL1532966

C=CC(=O)OCCCCCCOc1ccc(C2CCC(CCCCC)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 1/20 0.47
S1PR3 Q99500 1/20 0.45
TP53 P04637 1/20 0.42
THRB P10828 1/20 0.42
CYP2C9 P11712 1/20 0.42
PLA2G4B P0C869 1/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
S1PR5 Q9H228 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1533120 1.00 TSHR (0.48) TSHRHPGDRAB9AS1PR3TP53
SCHEMBL1532965 1.00 TSHR (0.48) TSHRHPGDRAB9AS1PR3TP53
SCHEMBL1533123 1.00 TSHR (0.48) TSHRHPGDRAB9AS1PR3TP53
SCHEMBL16425379 0.99 TSHR (0.49) TSHRHPGDRAB9AS1PR3TP53
SCHEMBL19294803 0.97 RAB9A (0.45) TSHRHPGDRAB9AS1PR3TP53
SCHEMBL19722504 0.94 THRB (0.49) TSHRHPGDRAB9AS1PR3THRB
SCHEMBL12173352 0.94 THRB (0.47) TSHRHPGDRAB9ATHRBCYP2C9
SCHEMBL12173347 0.94 THRB (0.47) TSHRHPGDRAB9ATHRBCYP2C9
SCHEMBL1533011 0.93 CYP2C9 (0.49) TSHRHPGDRAB9AS1PR3TP53
SCHEMBL1533013 0.93 CYP2C9 (0.49) TSHRHPGDRAB9AS1PR3TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230367157-A1 DIMMING DEVICE, MANUFACTURING METHOD THEREOF, AND SMART WINDOW TOYO LIMITED (JP) 2023-11-16 US disclosed
US-9080100-B2 Polymerizable liquid crystal composition JNC CORPORATION (JP) 2015-07-14 US disclosed
US-20150029446-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND OPTICAL ANISOTROPIC FILM JNC PETROCHEMICAL CORPORATION (JP) 2015-01-29 US disclosed
US-8168734-B2 Lateral alpha-substituted acrylate compound and polymer thereof JNC CORPORATION (JP) 2012-05-01 US disclosed
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF CHISSO CORPORATION (JP) 2011-06-16 US disclosed
US-7919648-B2 Lateral α-substituted acrylate compound and polymer thereof CHISSO CORPORATION (JP) 2011-04-05 US disclosed
EP-1754768-B1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND OPTICALLY ANISOTROPIC BODY DAINIPPON INK & CHEMICALS (JP) 2011-03-30 EP disclosed
US-7449223-B2 containing an additive that improves the level of defects in the vicinity of the air interface for an optically anisotropic medium that exhibits either tilted alignment or horizontal alignment DAINIPPON INK AND CHEMICALS, INC. (JP) 2008-11-11 US disclosed
US-7357964-B2 Liquid-crystalline vinyl ketone derivatives and their polymers CHISSO CORPORATION (JP) 2008-04-15 US disclosed
US-20070170394-A1 Polymerizable liquid crystal composition and optically anisotropic medium DAINIPPON INK AND CHEMICALS, INC. (JP) 2007-07-26 US disclosed
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof CHISSO CORPORATION 2007-06-14 US disclosed
EP-1754768-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND OPTICALLY ANISOTROPIC BODY Dainippon Ink and Chemicals, Incorporated (JP) 2007-02-21 EP disclosed
US-7157124-B2 Polymerizable compounds and their polymers CHISSO PETROCHEMICAL CORPORATION (JP) 2007-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF LEF1, AFF1, CNKSR1 TSHR 1525/4885HPGD 4842/4885RAB9A 462/4885
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof AFF1, CNKSR1, LEF1 TSHR 1335/4885HPGD 4876/4885RAB9A 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.